Full profile interview: SWOT
11 May 2022

GlucoRx
Full profile interview
29 Nov 2021

Tidepool
Tidepool is a 501© (3) nonprofit organization focused on diabetes management with headquarters in the USA. IDTechEx analysts Brendan Beh and Dr Nadia Tsao interviewed Tidepool Community and Clinic Success Manager Christopher Snider on November 22, 2021.
Full profile interview
26 Nov 2021

Fitscript
Fitscript is a digital health company looking at diabetes management via exercise therapy. IDTechEx analysts Brendan Beh and Dr Nadia Tsao interviewed Fitscript Chief Clinical Strategy Officer LaurieAnn Scher on the 22nd of November, 2021.
Full profile interview
19 Nov 2021

SNAQ
SNAQ is a digital health startup commercializing a AI-enabled logbook for food tracking. IDTechEx analysts Nadia Tsao and Brendan Beh interviewed SNAQ CEO Aurelian Briner on 17 Nov 2021.
External press release
10 Nov 2021

Treating Neurological Disorders with Brain Implants
INBRAIN uses technology developed by Graphene Flagship partners ICN2, ICREA and the University of Manchester to develop smart devices for patients with neuronal disorders, like Parkinson's or epilepsy. The Graphene Flagship ecosystem was key to the development of these innovative technologies.
Update
16 Aug 2021

Medtronic
At Cardio Wearables 2021, Dr Rohan Sonawane, Sr Medical Affairs Program Manager, presented Medronic's product offerings in the cardiac rhythm space, focusing on their Reveal LINQ™ implantable cardiac monitor.
Full profile interview
10 Jun 2021

ZPower
Founded in 1996, ZPower develops and commercializes silver-zinc batteries. In 2013, ZPower introduced silver-zinc rechargeable batteries for the hearing industry.
Full profile interview
27 May 2021

ZPower, LLC
Founded in 1996, ZPower develops and commercializes silver-zinc batteries. In 2013, ZPower introduced silver-zinc rechargeable batteries for the hearing industry.
External press release
30 Mar 2021

INBRAIN Neuroelectronics Intelligent Graphene Based Neural Implants
Existing brain interfaces are based on metals such as platinum and iridium, which impose significant restrictions in terms of miniaturisation and signal resolution, and therefore cause considerable side effects. For this reason, there is a 50% rejection rate in candidate patients. Graphene Flagship spin-off INBRAIN Neuroelectronics uses a disruptive technology based on graphene which will overcome the current limitations of metal-based neural interfaces.
10 Mar 2021

Retinal Implants can Give Artificial Vision to the Blind
Being able to make blind people see again sounds like the stuff of miracles or even science fiction. And it has always been one of the biggest challenges for scientists.
External press release
28 Oct 2020

Medtronic Venous Stent Receives U.S. FDA Approval
Medtronic plc, the global leader in medical technology, recently announced it has received U.S. FDA approval for the Abre™ venous self-expanding stent system.
External press release
14 Oct 2020

SNI - Novel Sacral Nerve Stimulator to Treat Bladder Incontinence
Soin Neuroscience Inc. (SNI), a biotech startup based in Dayton, Ohio, has developed a novel implantable sacral nerve stimulator to treat bladder incontinence.
Background
16 Jul 2020

Medtrum Technologies
Medtrum Technologies are a Chinese company commercialising diabetes management devices including CGM and insulin pumps. This profile looks at their activity over the last decade.
Background
8 Jul 2020

Abbott Diabetes Care
This is a comprehensive review of the business and technology of Abbott Diabetes Care, assembled from company reports and extensive academic literature review, and supported by additional interview comments over several years. It focuses primarily on the technology behind their market leading FreeStyle™ Libre™ CGM device, which generated over $1.8bn in revenue in 2019.